Replies to post #335369 on Amarin Corp Plc (AMRN)

[Lrich]

I think the R60 not being immediately discarded, plus the SC taking interest has given them pause.

The risk reward isn't good for them to enter the market right here, building up supply, then selling, then possibly being held liable for damages. If JT is being even half honest, then the profit margin for generics is terrible, so the decent chance of being left "holding the bag" isn't worth the small amount of profits they could eke out.

Losing these court cases though opens up the floodgates I'd wager.

[alm2]

ralphy
Whist Dr reddy may have intended to enter the market they can see first hand that litigation could await them as to infringement if they did and over and above there are clearly issues facing generics (as per Hikma) as to supply
One suspects that no other generic will wish to enter the market until litigation is over - a years wait for example
-Would probably be enough to allow the litigation to clear -if Amarin fails in litigation on the three fronts they can then come into the market without concern
So I doubt anyone else will join the generic party for a long time -and let us hope never on the basis of success in litigation
Alm

[lizzy241]

ralphey, Teva withdrew their GV and Dr Reddy had till around March to launch but didn't.

https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=209499#38205